Title: Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)
Authors: Rivera, Luis; Biswal, Shibadas; Llorens, Xavier Sáez; Reynales, Humberto; Medina, Eduardo López; Tabora, Charissa Borja; Bravo, Lulu; Sirivichayakul, Chukiat; Kosalaraksa, Pope; Vargas, Luis Martinez; Yu, Delia; Watanaveeradej, Veerachai; Espinoza, Felix; Dietze, Reynaldo; Fernando, LakKumar; Wickramasinghe, Pujitha; Moreira Junior, Edson Duarte; Fernando, Asvini D.; Gunasekera, Dulanie; Luz, Kleber; Cunha, Rivaldo Venâncio da; Rauscher, Martina; Zent, Olaf; Liu, Mengya; Hoffman, Elaine; LeFevre, Inge; Tricou, Vianney; Wallace, Derek; Alera, Maria Theresa; Borkowski, Astrid; TIDES study group
Description: 1Hospital Maternidad Nuestra Senora de Altagracia, Santo Domingo, Dominican Republic; 2Takeda Vaccines, Inc., Boston, Massachusetts, USA; 3Hospital del Niño Dr. José Renán Esquivel, Sistema
Nacional de Investigación at SENACYT, Centro de Vacunación Internacional (Cevaxin), Panama City, Panama; 4Centro de Atención e Investigación Médica, CAIMED, Bogotá, Colombia; 5Centro
de Estudios en Infectología Pediátrica, Universidad del Valle and Centro Medico Imbanaco, Cali, Colombia; 6Research Institute For Tropical Medicine, Muntinlupa, Philippines; 7University of the
Philippines Manila, Ermita, Philippines; 8Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; 9Faculty of Medicine, Khon Kaen University, Khon
Kaen, Thailand; 10CAIMED, Dominicana, Santo Domingo, Dominican Republic; 11De La Salle Medical and Health Sciences Institute, Dasmariñas, Philippines; 12Phramongkutklao Hospital, Bangkok,
Thailand; 13National Autonomous University of Nicaragua, León, Nicaragua; 14Núcleo de Doenças Infecciosas, Centro de Ciencias da Saude-UFES, Vitória, Brazil; 15Centre for Clinical Management
of Dengue & Dengue Haemorrhagic Fever, Negombo General Hospital, Negombo, Sri Lanka; 16University of Colombo, Colombo, Sri Lanka; 17Associação Obras Sociais Irmã Dulce Hospital Santo
Antônio and Oswaldo Cruz Foundation, Bahia, Brazil; 18Faculty of Medicine, University of Kelaniya, Colombo, Sri Lanka; 19Faculty of Medical Sciences, University of Sri Jayawardenenpura,
Colombo, Sri Lanka; 20Instituto de Medicina Tropical da Universidade Federal do Rio Grande do Norte, Natal, Brazil; 21Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil; 22Takeda
Pharmaceuticals International AG, Zurich, Switzerland; and 23Philippines-Armed Forces Research Institute of Medical Sciences Virology Research Unit, Cebu City, Philippines